Hap Trading, LLC Cara Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$7.45 - $13.84 $75,245 - $139,784	-10,100 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$9.94 - $12.65 $50,694 - $64,515	-5,100 Reduced 33.55%	10,100 $6,000
Q4 2021 Feb 14, 2022	SELL	$11.99 - $18.14 $31,174 - $47,164	-2,600 Reduced 14.61%	15,200 $24,000
Q3 2021 Nov 10, 2021	SELL	$11.55 - $16.06 $73,920 - $102,783	-6,400 Reduced 26.45%	17,800 $21,000
Q2 2021 Aug 11, 2021	BUY	$12.38 - $29.19 $151,036 - $356,118	12,200 Added 101.67%	24,200 $47,000
Q4 2020 Feb 16, 2021	SELL	$12.72 - $16.16 $17,808 - $22,624	-1,400 Reduced 10.45%	12,000 $9,000
Q3 2020 Nov 13, 2020	BUY	$12.34 - $17.92 $165,356 - $240,128	13,400 New	13,400 $4,000
Q2 2020 Aug 10, 2020	SELL	$12.39 - $17.33 $255,234 - $356,997	-20,600 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$9.12 - $17.78 $79,344 - $154,686	8,700 Added 73.11%	20,600 $16,000
Q4 2019 Feb 11, 2020	BUY	$16.11 - $25.98 $191,709 - $309,162	11,900 New	11,900 $18,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.